VANI

1.1404.59%
AE

Anthony Edward Baldor

Chief Financial Officer

Mr. Anthony Edward Baldor, M.B.A., M.I.D.S., is Chief Financial Officer of Vivani Medical, Inc. from June 2025. He is a seasoned professional with over 20 years of financial management experience in the biotechnology sector, specializing in fundraising, business development and corporate strategy. He began his career at the Harvard Skin Disease Research Center of Brigham and Women's Hospital, Dana Farber Cancer Institute and the Broad Institute at MIT and Harvard, where he developed Cequent Pharmaceuticals. He served as an Associate at RMI Partners before becoming an Equity Associate at Jefferies LLC in the Research Division, where he worked until July 2019. As Director of Business Development at Cambridge Biolabs, he provided marketing, fundraising and operations support to several domestic and international biotech startups, earning multiple grants and partnerships for his efforts. Prior to joining Vivani, Mr. Baldor was the Chief Financial Officer at Diakonos Oncology Corp., leading the company’s Series Seed and Series A financings and served as Vice President of Corporate Strategy & Development at 4D Molecular Therapeutics, Inc., where he played a pivotal role in the company’s Series C financing, initial public offering and various key partnership activities. His extensive experience spans drug development, medical devices, diagnostics and research tools, with a strong background in immunology and oncology. Mr. Baldor holds an M.B.A. From Haas School of Business of University of California, Berkeley completed in 2014 and a Master’s of Information and Data Science from the University of California, Berkeley and a B.A. in Neuroscience from Vassar College. He has been recognized with the Mayfield Fellowship, the Jack Larson Fellowship and the Kauffman Fellowship.

Positions